Interní Med. 2008; 10(9): 407-409

Laboratory diagnosis of multiple myeloma

MUDr. Tomáš Šálek
Biochemické oddělení nemocnice Uherské Hradiště

Multiple myeloma accounts for 10–15 % hematologic neoplasms. The most common clinical presentatin of multiple myeloma is back pain, anemia, leukopenia, trombocytopenia, proteinuria and neurologic involvement. In the past few years, there have been made some important breakthrough in understanding the biology of multiple myeloma. These findings are now opening the way to new horizons for diagnosing and monitoring of this disease. The first choise test for patients with symptoms of monoclonal gamapaties is serum protein electrophoresis alongside free light chain determination. Free light chain analysis is best for patienst who sufer from free light chain myeloma and AL amyloidosis, because these patients are not detected by serum protein electrophoresis. It accounts for 20 % patients. Serum free light chain analysis is more sensitive then testing for Bence Jones proteinuria. This new approach brings benefits for many patients with plasma cell disorders.

Keywords: Key words: multiple myeloma, serum protein electrophoresis, imunofixation electrophoresis, free light chains.

Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šálek T. Laboratory diagnosis of multiple myeloma. Interní Med. 2008;10(9):407-409.
Download citation

References

  1. Adam Z, Hájek R, Mayer J, et al. Mnohočetný myelom a další monoklonální gamapatie. vyd. Masarykova univerzita v Brně 1999.
  2. Adam Z. Česká myelomová skupina. Diagnostika a léčba mnohočetného myelomu - Doporučení vypracované Českou myelomovou skupinou, Myelomovou sekcí České hematologické společnosti a experty Slovenské republiky pro diagnostiku a léčbu mnohočetného myelomu. Transfuz. Hematol. dnes, 2005 (S1).
  3. Adam Z, et al. Diagnostika a léčba mnohočetného myelomu. Doporučení vypracované Českou myelomovou skupinou, Myelomovou sekcí ČHS a experty Slovenské republiky pro diagnostiku a léčbu mnohočetného myelomu. Vnitř Lék. 2005; 51 (Suppl 1): 3-51.
  4. Bradwell AR. Serum free light chain analysis fourth edition. U. S. A. Binding Site Inc: San Diego, Ca 92121.
  5. Hill PG, Forsyth JM, Rai B, Mayne S. Serum free light chains: An alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin. Chem., 2006; 52: 1743-1748. Go to original source... Go to PubMed...
  6. Pika T, Minařík J, Zemanová M. Sérové hladiny volných lehkých řetězců imunoglobulinu u mnohočetného myelomu a monoklonální gamapatie nejistého významu. Klin. Biochem. Metab., 16 (37) 2008; 2: 102-105.
  7. Jerry A. Katzmann, Roshini S. Abraham, Angela Dispenzieri, John A. Lust, and Robert A. Kyle. Diagnostic performance of quantitative and free light chain assays in clinical practice. Clin. Chem., 2005; 51: 878-881. Go to original source...
  8. Katzmann A, Dispenzieri A, Kyle A, et. al. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc. 2006; 81: 1575-1578. Go to original source... Go to PubMed...
  9. Ščudla V, Adam Z. Diagnostický význam a úskalí hodnocení roztěrového preparátu kostní dřeně u mnohočetného myelomu. Vnitř Lék. 2006; 52 (Suppl 2): 55-65. Go to PubMed...
  10. Ščudla V, Schneiderka P, Pika T. Klinický význam hodnocení sérových hladin volných lehkých řetězců imunoglobulinu u monoklonálních gamapatií. Klin. Bioch. Metab., 16 (37), 2008; 2: 76-83.
  11. Špička I., et al. Mnohočetný myelom a další monoklonální gamapatie. Praha: Galén 2005.
  12. Tichý M. Laboratorní analýza monoklonálních imunoglobulinů (paraproteinů). Český Těšín: FINIDR s. r. o., 1997.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.